ClinicalTrials.gg
RecruitingNCT07740447Updated Jul 31, 2026

Impact of Non-surgical Periodontal Treatment on Targeted Metabolomics

An interventional study of Probing depth reduction in Periodontitis, sponsored by University of Catania. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-07-31.

Sponsored by University of Catania · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

A double-blind randomized-controlled clinical trial is conducted in order to evaluate the impact of non-surgical periodontal treatment by means of minimally invasive approach MINST or Q-SI (quadrantwise) approach in subjects with periodontitis on targeted metabolomics in gingival crevicular fluid

Read the detailed description

A double-blind randomized-controlled clinical trial is conducted in order to evaluate the impact of non-surgical periodontal treatment in subjects with periodontitis.

All the 60 patients with periodontitis are assessed for clinical, periodontal, and gingival crevicular fluid following of minimally invasive approach MINST or Q-SI (quadrantwise).

Measurements are taken before and after initial periodontal treatment in the periodontal subjects.

02

Conditions studied

  • Periodontitis

Browse trials for

03

In context

Periodontitis

1,231 studies on the registry are indexed under Periodontitis; 295 are open to participants now.

This study's planned enrollment of 60 is above the median of 44 across 846 interventional studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

University of Catania is the lead sponsor of 71 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of Periodontitis

Exclusion criteria

Exclusion Criteria:

  • Periodontal treatment during the last 6 months
  • Use of antibiotics, NSAIDs, and during the last 6 months
  • Pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    MINST non surgical periodontal treatment

    Periodontitis patients treated by means of MINST. Patients were treated with non-surgical MINST periodontal treatment in a single session.

    Other: Probing depth reduction

  • Active comparator
    Q-SI non surgical periodontal treatment

    Periodontitis patients treated by means of Q-SI. Patients were treated with non-surgical quadrantwise periodontal treatment in 4 sessions, 1 session per week.

    Other: Probing depth reduction

Interventions

  • OtherProbing depth reduction

    Probing depth reduction in millimetres before and after treatment

06

What researchers measure

Primary outcomes

  1. Probing pocket depth

    Reduction in Probing Pocket Depth after treatment

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Study results

Supporting information: Study protocol

Time frame: 1 year

Access criteria: Pubmed

Data sharing details ↗ · pubmed.ncbi.nlm.nih.gov

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07740447
Lead sponsor
University of Catania
Responsible party
Gaetano Isola (Prof., University of Catania) — Principal investigator
First posted
Jul 31, 2026
Start date
May 4, 2026
Primary completion
Nov 16, 2026 (estimated)
Completion
Dec 18, 2026 (estimated)
Last update
Jul 31, 2026

Study contacts

Gaetano Isola
Contact
gaetano.isola@unict.it
0953785652

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion